Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
4.840
-0.480 (-9.02%)
At close: Oct 5, 2026, 4:00 PM EDT
4.850
+0.010 (0.21%)
Pre-market: Oct 6, 2026, 4:00 AM EDT
Impact BioMedical Market Cap
Impact BioMedical has a market cap or net worth of $41.35 million as of October 5, 2026. Its market cap has increased by 433.58% in one year.
Market Cap
41.35M
Enterprise Value
41.34M
1-Year Change
433.58%
Ranking
Category
Stock Price
$4.84
ChartMarket Cap Chart
Since the IPO on September 16, 2024, Impact BioMedical's market cap has increased from $34.49M to $41.35M, an increase of 19.88%. That is a compound annual growth rate of 9.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 5, 2026 | 41.35M | -21.73% |
| Dec 31, 2025 | 52.83M | 216.74% |
| Dec 31, 2024 | 16.68M | -51.64% |
| Sep 16, 2024 | 34.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 47.20M |
| Werewolf Therapeutics | 45.20M |
| Veru Inc. | 43.48M |
| Grace Therapeutics | 43.33M |
| Lite Strategy | 42.57M |
| CEL-SCI | 42.57M |
| Filana Therapeutics | 42.02M |
| Metagenomi Therapeutics | 39.48M |